Community/Retail

CVS Health has announced Be The First, a five-year $50 million initiative to help deliver the nation's first tobacco-free generation.

Sunscreen can do a lot more than prevent painful sunburn.

By mid-April, pharmacists in California should have full authority to distribute hormonal contraception such as the pill, patch, ring, and shot.

Next week brings our nation's greatest teambuilding event: March Madness.

Highly active antiretroviral therapy has dramatically curtailed HIV transmission and AIDS mortality.

Susan Cornell, PharmD, CDE, FAPhA, FAADE forecasts the future landscape for antidiabetic agents recommended as a second-line treatment for type 2 diabetics.

The FDA has approved Janssen Biotech's ibrutinib capsules for treatment-naïve patients with chronic lymphocytic leukemia.

Jon Roth, CEO of the California Pharmacists Association, discusses the protocol for pharmacists when they are dispensing birth control.

Jon Roth, CEO of the California Pharmacists Association, discusses the successes and challenges California pharmacists have faced in dispensing naloxone.

Susan Cornell, PharmD, CDE, FAPhA, FAADE discusses the patient counseling points pharmacists should be aware of for antidiabetic agents.

Susan Cornell, PharmD, CDE, FAPhA, FAADE outlines the classes of antidiabetic agents recommended as a second-line treatment for type 2 diabetics.

Merck has applauded the US Department of Veterans Affairs for broadening access to treatment for Veterans with chronic hepatitis C virus infection.

Jeffrey Goad, PharmD, MPH, FAPhA, discusses some promising new vaccines that are currently in the development pipeline.

The number of pharmacists looking for work currently exceeds the number of pharmacist jobs available, according to new data compiled by the Pharmacy Workforce Center.

Last year, after much discussion among medical professionals and health policy experts, there was a change to a more value-based approach led by the Centers for Medicare & Medicaid Services.

The National Committee for Quality Assurance recently recognized naviHealth for its commitment to quality care and patient services with its Certification in Utilization Management.

Independent pharmacists' ability to provide personalized care gives them a competitive advantage within value-based health care models.

Why are independents so successful? Why are retail pharmacies losing patients? Read three lessons independent pharmacists can teach retail pharmacists aiding in their success.

Entrepreneurship has a strong history in health care.

Patients who logged into Walmart's online pharmacy service last month may have been able to view other patients' prescription history and some basic personal information because of a software coding error.

The FDA has accepted Egalet Corporation's new drug application for morphine sulfate extended-release tablets (Arymo ER).

The ambiguous definition of polypharmacy is contributing to the inappropriate use of medications.

The FDA has approved coagulation factor IX (recombinant), albumin fusion protein (Idelvion) for the treatment of hemophilia B in patients aged 12 years and older.

Did you know that March is DVT Awareness Month?

Jon Roth, CEO of the California Pharmacists Association, discusses the status of birth control prescribing among pharmacists in California.

Although multiple-choice exams have some limits, active learning can still be promoted by engaging pharmacy students in course materials.

Many patients wouldn't question the use of doctor" when addressing physicians, dentists, or even optometrists, but the title likely seems foreign when addressing pharmacists, physical therapists, and nurse practitioners.

While students on spring break are eagerly enjoying some fun in the sun," they're more likely to participate in binge drinking, engage in casual sex, and fall victim to alcohol-related injuries.

You've been working harder and harder as the years go by, but you're doubtlessly seeing fewer and fewer rewards as time passes.

The first reversal agent approved for the anticoagulant dabigatran (Pradaxa) has shown promise in patients with brain hemorrhage.